These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9821022)

  • 21. Molecular modeling of enzymes and receptors involved in carcinogenesis: QSARs and compact-3D.
    Lewis DF; Moereels H; Lake BG; Ioannides C; Parke DV
    Drug Metab Rev; 1994; 26(1-2):261-85. PubMed ID: 8082570
    [No Abstract]   [Full Text] [Related]  

  • 22. Computer-aided rodent carcinogenicity prediction.
    Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
    Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment.
    Gonzalez FJ; Crespi CL; Gelboin HV
    Mutat Res; 1991 Mar; 247(1):113-27. PubMed ID: 2002797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of computers in the safety evaluation of drugs and other chemicals.
    Ioannides C; Lewis DF; Parke DV
    Eur J Drug Metab Pharmacokinet; 1994; 19(3):225-33. PubMed ID: 7867665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel naïve Bayes classification models for predicting the carcinogenicity of chemicals.
    Zhang H; Cao ZX; Li M; Li YZ; Peng C
    Food Chem Toxicol; 2016 Nov; 97():141-149. PubMed ID: 27597133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines.
    Sistare FD; Morton D; Alden C; Christensen J; Keller D; Jonghe SD; Storer RD; Reddy MV; Kraynak A; Trela B; Bienvenu JG; Bjurström S; Bosmans V; Brewster D; Colman K; Dominick M; Evans J; Hailey JR; Kinter L; Liu M; Mahrt C; Marien D; Myer J; Perry R; Potenta D; Roth A; Sherratt P; Singer T; Slim R; Soper K; Fransson-Steen R; Stoltz J; Turner O; Turnquist S; van Heerden M; Woicke J; DeGeorge JJ
    Toxicol Pathol; 2011 Jun; 39(4):716-44. PubMed ID: 21666103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfection of cytochrome P450 cDNAs into mammalian cells used in mutation and transformation assays.
    Langenbach R; Crespi C; Davies R; Rudo K; Smith P; Hansen S; Ross J; Siegfried J; Nesnow S
    Prog Clin Biol Res; 1990; 340D():239-48. PubMed ID: 2371297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of human cytochrome P450-expressing cell lines: application in mutagenicity testing of ochratoxin A.
    de Groene EM; Hassing IG; Blom MJ; Seinen W; Fink-Gremmels J; Horbach GJ
    Cancer Res; 1996 Jan; 56(2):299-304. PubMed ID: 8542584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts.
    Benigni R; Bossa C; Tcheremenskaia O
    Chem Rev; 2013 May; 113(5):2940-57. PubMed ID: 23469814
    [No Abstract]   [Full Text] [Related]  

  • 30. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety evaluations of food chemicals by "COMPACT". 1. A study of some acyclic terpenes.
    Lewis DF; Ioannides C; Walker R; Parke DV
    Food Chem Toxicol; 1994 Nov; 32(11):1053-9. PubMed ID: 7959460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinogenicity evaluations and ongoing studies: the IARC databases.
    Vainio H; Coleman M; Wilbourn J
    Environ Health Perspect; 1991 Dec; 96():5-9. PubMed ID: 1820277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro mammalian cell genotoxicity assays: their use and interpretation.
    McGregor D
    Prog Clin Biol Res; 1990; 340B():159-69. PubMed ID: 2203003
    [No Abstract]   [Full Text] [Related]  

  • 35. Computer modelling and in vitro tests in the safety evaluation of chemicals-Strategic applications.
    Parke DV; Ioannides C; Lewis DF
    Toxicol In Vitro; 1990; 4(4-5):680-5. PubMed ID: 20702255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
    Slamenová D
    Neoplasma; 2001; 48(6):425-34. PubMed ID: 11949832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invited contribution: an objective approach to the development of short-term tests predictive of carcinogenicity.
    Rosenkranz HS; Ennever FK; Chankong V; Pet-Edwards J; Haimes YY
    Cell Biol Toxicol; 1986 Dec; 2(4):425-40. PubMed ID: 3077082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
    Cruzan G; Bus J; Banton M; Gingell R; Carlson G
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.